PCSA offering history
Every offering-related filing in Processa Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 692 filings back to Oct 28, 2011.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 29, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 7, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 25, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 18, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 17, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 13, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 29, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jan 27, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 27, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 16, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 20, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| May 28, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 28, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 21, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 29, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jan 26, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 22, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 29, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Feb 13, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 24, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 20, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 9, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 30, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 12, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 12, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 2, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 18, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 5, 2020 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 1, 2020 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Oct 1, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 30, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 25, 2020 | RW → | WITHDRAWN | Registration withdrawn |
| Sep 17, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 17, 2020 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 13, 2019 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 14, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 9, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 9, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 30, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 9, 2018 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
PCSA offering FAQ
When did PCSA last execute an offering?
Per SEC filings, Processa Pharmaceuticals, Inc.'s most recent priced offering document is a 8-K filed 2026-07-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did PCSA last announce or register an offering?
The most recent registration is a S-1 filed 2025-06-13. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.